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1172-38 The Scal Atrial Natriuretic Peptide Gene War/ante Are 
Associated With the Extent  of Coronary Artery  Disease 
Dariusz Clecwlerz. Marcin Gruchala, Bartosz Wasag, Redoslaw Targonski, Karolina 
Ochman, Witold Dubaniewicz, Wojciech Sobiczewski, Jerzy Bellwon, Adam Grzybowski, 
Bartosz Curyllo, Andrzej Rynkiewicz, Department of Invasive Cardiology, First 
Department of Cardiology Medical University of Gdansk, Gdansk, Poland, Department of 
Biology and Genetics Medical University of Gdansk, Gdansk, Poland. 
Background Atdal natriuretic peptide (ANP) is a circulating hormone mainly of cardiac 
origin whose biological actions include promotion of natriuresis and vasodilatation, inhibi- 
tion of growth, and suppression of the renin-angiotensin and endothelin-1 (ET-1) sys- 
tems. Transition T2238~C leading to the loss of the Scal restriction site in the atria/ 
natriuretic peptide (ANP) precursor gene and potentialy to the translation of ANP with two 
additional arginines, has been suggested to be associated with salt-sensitive hyperten- 
sion. The aim of our study was to investigate whether there is an association between the 
Scal ANP gene polymorphism and extent of coronary artery disease among patients with 
significant coronary artery stenosis confirmed by means of angiography (at least one cor- 
onary artery with >50% lumen narrowing). 
Methods The study was performed in 847 consecutive, Caucasian patients: 719 males 
and 128 females (mean age 47±11 years) with significant coronary artery stenosis con- 
firmed by elective coronary angiography. Screening for the T2238~C substitution was 
performed by polymerase chain reaction of genomic DNA, followed by Scal digestion 
and agarose gel electrophoresis. 
Results We observed increasing prevalence of homozygous A2A2 genotype from 23% 
in single-vessel disease patients to 28% and 31% in two- and three-vessel disease sub- 
jects, respectively. In a logistic regression model adjusting for other coronary risk factors 
the odds ratio for the association of the A2A2 genotybe and multiple-vessel coronary ath- 
srosclerosis was 1.45 (95%CI 1.02-2.06, p<0.04). The Sca/ANP genotypes distribution 
did not differ in terms of age, sex, body mass index, plasma lipids, hypertension, diabe- 
tes mellitus and family CAD history in studied group. 
Conclusion Our results from this relatively large sample of Caucasian patients with sig- 
nificant coronary ertery stanosis suggest that the A2A2 genotype of $ca/ANP polymor- 
phism may be associated with more severe coronary atherosclerosis. 
1172-39 Inter leuk in-6  Concent ra t ion  Predicts Coronary Artery  
Disease Better  Than High-Sensitivity C-Reactive Prote in  
Brent P. Davis. Joseph B. Muhlestein, John F. Cadquist, Jason M. Lappe', Benjamin D. 
Home, Jeffrey L. Anderson, LDS Hospital, Salt Lake Ci~ Utah, University of Utah, Salt 
Lake Ci~ Utah. 
Background: Interleukin (IL)-I beta and tumor necrosis factor alpha (TNF-alpha) are 
cytokines primarily produced dudng inflammatory responses. They induce IL-6 which in 
turn potentiates the biosynthesis of acute phase proteins (e.g. fibrinogen, C-reactive pro- 
tain [CRP]) by hepatocy~as. Elevated CRP increases the risk of coronary artery disease 
(CAD), and preliminary evidence suggests IL-6 may predict CAD independent of high- 
sensitivity (hs)CRP. The objective of this study was to determine the predictive value of 
these three related cytokines and hsCRP for CAD. 
Methods: Levels of IL-1 beta, IL-6, TNF-alpha, and hsCRP were measured (automated 
DPC Immulite platform) in 434 patients. Cases (n=217) had angiographicalty proven 
CAD (>1 lesion of >70% stanosis) and controls (n=217) had no stsnosis (all <10%). 
Cases were matched 1:1 to controls by age, gender, and time period of angiogram. Other 
dsk factors were recorded at angiography in a cross-sectional study design that was ana- 
lyzed by logistic regression. 
Results: Average patient age was 62±11 years and 51% were male. In univariate analy- 
sis, elevated risk for CAD was associated with high hsCRP (hazard ratio [HR]=1.59, 95% 
confidence interval [CI]=t .02-2.5, p=0.04) and high IL-6 (HR=1.92, C1=1.2-3.0, p=0.004), 
but not IL-1 beta or TNF-alpha. IL-6 concentration was mildly correlated with hsCRP 
(r=0.29), but not with IL-1 or TNF. In models entering both, high IL-6 (HR=1.83, p=0.01) 
but not high hsCRP (HR=1.48, p=0.10) predicted CAD. Modeled as continuous variables, 
the result more strongly favored IL-6 (univariate: p=0.02, multivariate: p=0.02) compared 
to hsCRP (univadata: p=0.08, multivariata: p=0.46). In the final multivariate model, only 
high IL-6 remained a significant predictor of CAD (HR=t.91, C1=1.2-3.0, p=0.006). 
Conclusion: IL-6 significantly predicted CAD, but also appeared to account for the pre- 
dictive value of hsCRP. This supports a previous finding that IL-6 predicts CAD, but also 
suggests that IL-6 may be a more sensitive descriptor of risk than is hsCRP. Further stud- 
ies are required to explore the relationship between hsCRP and IL-6 and determine the 
utility of measuring IL-6 on an automated assay in a clinical setting. 
1172-40 Bra in  Natr iuret ic  Pept ide  Levels Are Associated With 
Dobutamine Induced Myocardial Ischemia 
Junko Watanabe. Hisako Tsuji, Toshiji Iwasaka, Maureen Martin, Annitta Morehead, 
James Thomas, Michael S. Lauer, Cleveland Clinic Foundation, Cleveland, Ohio, Kansai 
Medical Universi~ Moriguchi-City, Japan. 
Background: Plasma Brain Natriurefic Peptide (BNP) levels have been associated with 
resting LV systolic dysfunction and exercise-induced ischemia. It is not known whether 
BNP correlates with pharmacologically induced ischemia. 
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Methods: We obtained BNP levels before and after dobutamine stress in 317 patients 
(age 68+11, 46% female) who had crsatinine < 1.5 mg/dl and did not have valve disease. 
Echocardiogram readings were blinded to BNP levels. Ischemia was defined as new wall 
motion abnormalities with stress. 
Results: Median BNP level at rest was 29 pg/ml (25 th and 75 th percentiles 12 and 70 pg/ 
ml), while median BNP level just after stress was similar at 29 pg/ml (25 th and 75 t~ per- 
centiles 10 and 72 pg/ml). Ischemia was noted in 31 patients (10%) while scar was 
present in 81 (26%). Both ischemia and scar were more common as the resting or exer- 
cise BNP levels increased; the Figure shows rates for tertiles of rest BNP. After adjusting 
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for age, gender, and left ventdcular ejection fraction, BNP before and after stress was 
predictive of ischemia (for both measures one SD increase in the log of BNP adjusted 
odds ratio [OR] 2.0, 95% CI 1.3 to 3.0, P=0.002). Similarly, after adjusting for age, sex, 
and ejection fraction, BNP at rest predicted scar (for one SD increase in log of BNP 
adjusted OR 2.1,95% 1.3 to 2.6, P=0.006). The change in BNP with stress was not cor- 
related with the presence of ischemia.Concluslon= Resting BNP levels are predictive of 
dobutamine-induced ischemia. Larger studies are needed to confirm this finding. 
1172-41 Does the Gender of the Card io log is t  Have an Impact on 
the Nonlnvasive Diagnosis of Coronary Artery Disease 
in Women and Men? 
Barbara Buergi Wegmann, Gabor Suetsch, Hans Rickli, Burkhart Seifert, Joerg 
Muntwyler, Wolfgang Amann, Wolfgang Kiowski, Thomas F. Luescher, Jurej Turina, 
Christine I-I. Attenhofer ,,10~t, Division of Cardiology, University Hospital Zurich, Zurich, 
Switzerland. 
BACKGROUND: It is unknown if female physicians are better suited to take a patient his- 
tory in female patients than their male colleagues.- METHODS. We investigated the 
impact of the gender of physicians and patients on accuracy of diagnosing coronary 
artery disease (CAD) based on patient history only in a prospective study conducted from 
September 2000 to January 2001 screening 1,082 patients undergoing coronary angiog- 
raphy for suspected CAD; known CAD was an exclusion criterion. The inclusion criteria 
were met by 144 consecutive patients (47 females); CAD was present in 20 females 
(43%) and 70 males (72%). All patients were invervlewed by both an experienced male 
and female cardiologist who had to state before coronary angiography if CAD was 
present relying solely on the patient interview. All subjects answered a questionnaire cov- 
ering their symptoms, risk factors, and own illness perception. Then, diagnostic accuracy 
for CAD of history-taking of male and female cardiologists, exercise testing, self-assess- 
ment of patients, and questionnaire were compared. - RESULTS. Diagnostic accuracy 
was not different between male (79 %) and female (79 %) cardiologists, comparable to 
results of exercise testing (74 %) but better than self-assessment by patients (65 %; 
p--0.01) or by a questionnaire (68 %; p=0.01). Accuracy of female cardiologists was sig- 
nificantly better in male than in female patients (85 % versus 66 %, p=0.01), while the 
accuracy of male physicians was not influenced by patient gender (p=0.93) as female 
cardiologists tended to overestimate the presence of CAD in female patients (specificity 
48% versus 74%, p=0.04), but had a better specificity in male patients than their male 
colleagues (79 % versus 59 %, p=0.51).- CONCLUSIONS. Female cardiologists do not 
assess female patients more accurately than their male colleagues. Diagnostic accuracy 
of male and female cardiologists is excellent. Both tend to better assess patients of the 
opposite gender - especially female cardiologists. The diagnostic accuracy of history tak- 
ing is better than assessment by a questionnaire or self-assessment of patients. An 
impact of the gender of the physician on the accuracy to diagnose CAD by history taking 
may exist. 
1172-42 Value o f  Noninvasive Testing fo r  the Detect ion of  
Coronary Artery  Disease and Assessment of Cardiac 
Risk in Renal Transplant Candidates 
Jose J. Lima. Marcelo L. Vieira, Jose L. Andrade, Eulogle Martinez-Fitho, Jose Soares, 
Eduardo M. Kdeger, Heart Institute (InCor), University of S~o Paulo Medical School, S&o 
Paulo, Brazil. 
Background: the purpose of the study was to evaluate the usefulness of dobutamine 
stress echocardiography (DSE) and of radionuclide pertusion imaging (dipyddamole sin- 
gle photon emission computed tomography, SPECT) for the detection ol coronary artery 
disease (CAD) and assessment of cardiac risk in renal transplant candidates (RTC) 
using coronary anglegraphy (CA) as gold standard. 
Methods: eighty (80) high-risk RTC (55 + 8 years old, time on dialysis 58 + 30 months, 62 
males, 56 Caucasians, 69 hypertensives, 26 smokers, 19 diabetics, 22 with serum total* 
cholesterol higher than 200 mg/100 ml, 78 with LV hypertrophy (Echo), 22 with angina, 
10 with previous stroke and 7 with previous myocardial infarction (MI) were studied by 
DSE, SPECT and CA, in this order. CAD was defined as at least 70 % stanosis in one or 
more epicardial arteries. 
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Results: CAD was detected by CA in 31 (39%) of the patients (3 or more vessels, 10, 2 
vessels, 5 and, 1 vessel, 16 cases). The prevalences of MI, stroke and diabetes were 
higher among patients with CAD (p< 0.05). Age, gender, race, time on dialysis, BMI, 
blood pressure, serum lipids, hematocnt, LVMI, ejection fraction, smoking and angina did 
not discriminate the groups. The sensitivity, specificity, and positive and negative predic- 
tive values of the tests (assuming a prevalence of 39% of CAD) were the following. DSE: 
41,93, 78 and 71%; SPECT: 30, 98, 90 and 69 %, respectively. The combined use of the 
tests did not improve significantly the results. After 36 + 20 months, there were 3 (6.1%) 
major cardiac events among patients with normal coronaries or nonsignificant CAD and 9 
(29%) among patients with CAD (p= 0.004). Altered DSE and/or SPECT were not predic- 
tors of major cardiac events. 
Conclusions: DSE and SPECT presented good specificity but low sensitivity and nega- 
tive predictive values. In contrast with CA, they also did not correlate with the occurrence 
of major cardiac events. We conclude that, among high-risk RTC, DSE and SPECT can 
not be considered substitutes for CA in order to detect CAD and to assess cardiac risk. 
1172-43 Long-Term Outcome of New Onset Exertionel Angina in 
the Community: Prospective Eight-Year Follow-Up 
Compared With Asymptomatic Controls 
Manish M. Gandhi, Fiona C. Lampe, Avis M. Scantlebury, David A. Wood, NationalHeart 
and Lung Institute, London, United Kingdom, Royal Devon and Exeter Hospital 
(Cardiology), Exeter, United Kingdom. 
Background: Outcome data on new onset exertional angina (NOAP) in the community 
are largely limited to the Framingham Study, and pre-date the coronary revascularization 
era; contemporary outcome of NOAP in primary care is not known. Aim: to investigate 
long-term prognosis of NOAP in primary care compared with age and sex matched 
asymptomatic controls (CON) from the same population, 
Methods: In 1990-93, randomly selected primary care practices in Southampton, UK, 
with a population of 192,000, referred all patients presenting for the first time with sus- 
pected angina to a dedicated rapid access chest pain clinic. 
Results: A total of 110 consecutive patients with NOAP (Framingham definition), 
mean(SD)age 57(9.6) years, 64% male, and 110 healthy CON, mean(SD)age 57(9.3) 
years, 61% male, were prospectively followed-up for death from all causes, nonfatal 
myocardial infarction (MI), CABG and PTCA over a median of 8.2 years. Follow-up was 
99.5% complete. Event-free survival from death/MI was 73.2% for NOAP vs 93,2% for 
CON, log rank p<0,001 ; for the combined end-point of death/MI, CABG or PTCA (CE), it 
was 42.6% NOAP vs 93.2% CON, log rank p<0.001, For NOAP, annual event rates 
[%(SD)per year] were: all cause mortality 2.3(0.5), death/MI 3.9(0.7), and for CE 11(1.5); 
all event rates were higher in the first year compared with years 2-10 (risk ratio 4.5, 
p<0.001). Relative risk (95% CI) for NOAP vs CON was: all cause mortality, 
3.9(1.5,10.5), CE, 26.8(8.4,85.5). After eight years, 54% of surviving NOAP were symp- 
tom free. Of CON, 6% (6 of 98) reported chest pain. In multivariate analysis among 
NOAP, baseline symptom severity did not predict outcome; Bruce treadmill duration was 
independently associated with increased risk of the CE [RR 3.5, 95%CI 1.9,6.6]. With 
CABG/PTCA as a time dependent variable, a trend towards reduced risk of deatWMI [RR 
0.3(0.1,1.2) p=0.08] was observed. 
Conclusion: This is the first study to describe contemporary long-term outcome of 
NOAP in the community. Cardiac event rate was highest during the first year after pre- 
sentation, and was not predicted by baseline symptom severity; after eight years, less 
than a third of patients presenting with NOAP were free from a major cardiac event or 
symptoms. 
1172-44 Diabetes Is Assoc ia ted  With a Higher Risk of Death 
Than Is Prior Myocardial Infarction in the Sett ing of  
Coronary Disease: Results From the Duke 
Cardiovascular Database 
Darren K. McGuire, Sunil V. Rao, Peter J. Joski, Gregory W. Barsness, Eric D. Peterson, 
James G. Jollis, Mark N. Feinglos, Christopher B. Granger, University of Texas- 
Southwestern Medica/ Center, Da/las, Texas, Duke C/inica/ Research Institute, Durham, 
North Carc/ina. 
Background: Based on population studies and subset analyses from randomized trials, 
diabetes has been associated with an increase in cardiovascular risk similar in magni- 
tude to the "secondary" risk associated with prior myocardial infarction (MI). The prog- 
nostic importance of diabetes compared with prior MI on outcomes among patients with 
documented coronary artery disease (CAD) remains unclear. 
Methods: To evaluate the relative influence of diabetes and prior MI on outcomes among 
patients with documented coronary artery disease in a large prospective cohort, we ana- 
lyzed data on 18,481 patients undergoing cardiac catheterization at Duke from 1986- 
t999 who had CAD, defined as >_1 epicardial artery with >-75% stenosis. 
Results: In this group, 4574 (24.7%) had DM, Patients with DM were older, heavier, 
more likely female, more likely to have a history of hypertension, hyperlipidemia, CHF, 
and less likely to smoke. Among the DM subset, 2534 (55.4%) had a prior MI compared 
with 8414 (60.5%) of patients without DM. Mean follow-up was 6.5 +/-4.2 years. In unad- 
justed analyses, DM alone was associated with a much worse prognosis compared with 
a history of MI alone. (Figure) There was no evidence of a DM by MI interaction (p=0.72). 
Conclusion: Among patients with documented coronary artery disease, diabetes is 
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associated with greater long-term risk than is a history of myocardial infarction. These 
findings underscore the importance of developing more effective therapeutic strategies 
among this high-risk population. 
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1172-45 Sex Differences in the Prognostic Importance of 
Diabetes in Ischemic Heart Disease 
Michelle M. Graham. William A. Ghali, Peter D, Far•s, Merril L. Knudtson, for the 
APPROACH Investigators, University of Alberta, Edmonton, Canada, University of 
Calgary, Calga~ Canada. 
Background: Women with ischemic heart disease (IHD) are known to have poor out- 
comes compared to men. Previous studies have also suggested that the adverse prog- 
nosis associated with diabetes is greater in women. We sought to evaluate the prognosis 
associated with diabetes, in analyses stratified by sex, to determine if similar differences 
ere seen in an unsalected cohort of patients. 
Methods: Using APPROACH, a clinical data collection and follow-up initiative capturing 
all patients undergoing cardiac catheterization in Alberta, Canada, the relative signifi- 
cance of diabetes on long-term survival in men and women was evaluated; first in the 
general cohort with IHD, and then according to treatment strategy (medical therapy, per- 
cutaneous coronary intervention (PCI), or coronary artery bypass graft (CABG) surgery). 
Cox proportional hazard models were used to calculate the risk*adjusted hazard ratios 
(HR) for diabetes in men and women. 
Results: Women were more likely to have comorbidities such as diabetes, hypertension, 
cerebrovascular disease, and a history of heart failure (p<0.001). Mortality rates at one 
year were 4.7% in men (4.1% in non-diabetic patients and 7.4% in diabetic patients, 
n=13,152) and 6.8% in women (5.8% in non-diabetic patients and 9.6% in diabetic 
patients, n=4249, p<0.001 for sex comparison). When data were analysed for all patients 
we found that the HR associated with diabetes were 1.31 in men and 1.43 in woman. 
When we stratified according to treatment, the HR for diabetes in patients treated with 
PCI were 1.33 in men and 1.52 in women. HR for diabetes in patients treated with CABG 
were 1.23 in men and 1.28 in women, and for those treated medically were 1.34 in men 
and 1.42 in women. 
Conclusions: While women with IHD continue to have poor outcomes compared to 
men, in APPROACH we find only a slight sex difference in the prognostic importance of 
diabetes. However, we do find that the HR for diabetes differed most markedly in patients 
treated with PCI. Considering the finding in the BARI trial of poor prognosis with diabetes 
and PCI, our finding suggests that women with diabetes who undergo PCI may be a par- 
ticularly susceptible group. 
1172-46 High Neopterin Levels Predict Major Adverse Coronary 
Events in Patients With Chronic Stable Angina 
Sen Devadathan, Emmanouil Zouridakis, Della Cole, Juan Carlos Kaski, St George's 
Hospita/ Medica/ School London, United Kingdom. 
Background: Neoptedn, a pterydine derivative secreted by activated macrophages, has 
been shown to be elevated in patients with acute coronary syndromes and is associated 
with complex stenosis morphology in patients with unstable angina. The aim of the 
present study was to examine the prognostic significance of increased serum neoptedn 
levels in patients with chronic stable angina. 
Methods and Results: We studied 307 patients (28% women, mean age 63 ± 9 ys) with 
chronic stable angina. Serum neoptedn was measured using a commercially available 
immunoassay (ELISA) kit in blood samples drawn at study entry. All patients were fol- 
lowed up for a mean period of 12 ± 3 months and during that period 54 patients (17.6%) 
developed at least one major adverse coronary event (MACE: Acute myocardial infarc- 
tion, episodes of unstable angina, emergency revascularisation or cardiac death). There 
was no statistically significant difference in the prevalence of demographic and clinical 
variables between patients with and without MACE. The mean serum neopterin levels 
among patients with and without MACE were 7.19 ± 3.66 and 5,85 ± 3.31 nmol/I respec- 
tively (p=0.009). A positive correlation was seen between serum neoptedn level and the 
occurence of MACE ( r = 0.15, p<0.01). Multiple logistic regression analysis also 
revealed that high neopterin levels were an independent predictor of future adverse 
events (p=0.03). 
Conclusions: Serum neopterin level is an independent predictor of major adverse core- 
nary events in patients with chronic stable angina. This marker of atherosclerotic disease 
activity may be a useful adjunct to the risk stratification strategies of patients with core- 
nary artery disease. 
